The paper, “Effects of Trauma and Anxiety on Adherence in Pediatric Type 1 Diabetes,” originally appeared in Diabetes Spectrum.

CCTS Associate Director on Why Our Community Members are the Experts

The Center for Leading Innovation and Collaboration, housed at the NIH National Center for Advancing Translational Science (which funds the CCTS), highlighted the UK CCTS team science training program in its Insights to Inspire series.

The KL2 and TL1 programs train the next generation of clinical and translational researchers.

CCTS has awarded a total of $4m in pilot awards, with a 20:1 return on investment.

An expert on the deadly 1918 flu pandemic, Barry talks about lessons learned that crisis and parallels to the COVID-19 pandemic.

His book “The Great Influenza: The Story of the Deadliest Pandemic in History” was an NYT bestseller and named by the National Academies of Science as the year’s outstanding book on science or medicine.

The CCTS will host the acclaimed medical historian John M. Barry, author of "The Great Influenza: The Story of the Deadliest Pandemic in History," at the keynote panel of its 2021 Spring Research Days, to be held the afternoons of April 7 and 8.

The CCTS serves as the engine for UK's testing site of the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study ENSEMBLE 2, which is evaluating the safety and efficacy of a two-dose regimen of Janssen’s COVID-19 vaccine candidate.

The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, participated as a site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate.